Goals/Background: The aim of this study was to decipher whether end-stage liver failure modifies peripheral blood lymphocytes (PBL) in a homogeneous manner, independently of the base pathology, or, if on the contrary, PBL subsets show a different profile in each hepatic disease.
S
everal liver diseases culminate in hepatic failure, ultimately requiring liver transplantation. Hepatotrophic viruses like hepatitis C virus (HCV) and hepatitis B virus (HBV) are the main causes of chronic hepatitis cirrhosis, liver failure, and hepatocellular carcinoma worldwide; less than 10% of HBV-infected patients develop chronic hepatitis whereas more than 80% of HCV-infected ones do so. 1, 2 Both viruses elicit progressive liver injuries resulting in end-stage liver disease unless effectively eradicated. [2] [3] [4] HCV is now the most common cause of chronic viral hepatitis in the developed world and the most common cause of cirrhosis requiring liver transplantation. 5 Other nonviral causes that ultimately result in endstage liver disease requiring liver transplantation are alcoholism, hepatocellular carcinoma, and autoimmune liver diseases. The liver is the primary target organ injured during heavy alcohol consumption and, as a consequence, alcoholism is the second cause (30%) of hepatic transplantation. 6 Hepatocellular carcinoma is the fifth most common cancer worldwide, 7 with a poor prognosis and limited survival in the majority of patients. In Spain, hepatocellular carcinoma represents 14% of the indications for hepatic transplantation. 8 Finally, autoimmune hepatitis and primary biliary cirrhosis are the most frequent autoimmune liver pathologies, accounting for 2% and 5%, respectively, of liver transplants performed in our country. 8 It is well established that T lymphocytes are involved in the pathogenesis of important liver diseases and play a central role in inflammatory diseases such as viral hepatitis, autoimmune diseases, graft-versus-host disease, and allograft rejection. 9, 10 There is growing evidence that lymphocytes recruited into the liver are responsible for liver damage. 11 The participation of lymphocytes in different liver pathologies could be reflected in modifications of peripheral blood lymphocytes (PBL) subpopulations specific for each disease. On the contrary, chronic liver insufficiency produces systemic metabolic changes that modify the normal homeostasis of the immune system, and this could result in a common alteration in the PBL profile, independently of the base pathology. To investigate which of the 2 possibilities is true we have analyzed the PBL subpopulations in a cohort of end-stage liver disease patients just before liver transplantation.
Comparisons among the lymphocyte subpopulations in the diseases that frequently cause hepatic failure and are susceptible to be treated by liver transplantation have been also established.
MATERIALS AND METHODS

Patients and Healthy Donors
Blood samples were collected longitudinally from a total of 71 patients with end-stage liver disease, before liver transplantation at the Hospital 12 de Octubre (Madrid, Spain), between 2004 and 2005. The degree of hepatic dysfunction of the patients was measured by Child-Pugh-Turcotte (CPT) classification, and at the time of analysis all patients were B cirrhotics (7 to 9 points of the CPT classification); model of end-stage liver disease (MELD) score was under 24 for all excepting 3. These 3 were: acute liver failure, HCV, and alcoholic cirrhosis, patients who showed MELD scores of 29, 26, and 32, respectively (Table 1) . Written consent was obtained from all patients and the study protocol was approved by the Ethics Committee of the hospital. At the time of the study none of the patients was subjected to antiviral or immunosuppressor treatment, with the exception of HBV patients who were treated with lamivudine. Blood samples were also taken from 74 healthy volunteers. Patient characteristics and classification according to the base pathology are shown in Table 1 .
Flow Cytometric Analysis
A total of 12 different antibodies FITC, PE, and Cy5-labeled were used: anti-CD4, anti-CD8, anti-CD16, anti-CD19, anti-CD3 (Caltag, Burlingame, CA); anti-CD8, anti-CD4, anti-HLA-DR, anti-CD45RO (B-D Biosciences, San Diego, CA); anti-CD3/CD4/CD8CD45, anti-CD45RA (Beckman Coulter, Hialeah, FL), antiTCRab, and anti-TCRgd (Immunotech, Marseille, France). Stained lymphocytes were studied by flow cytometry with the use of EPICS XL-MCL fluorocytometer (Coulter Electronics).
The relative proportions of lymphocyte subpopulations were determined as a percentage of the total number of cells in a lymphogate defined by forward and side scatter properties.
Statistical Analysis
Data are expressed as mean ± SD for percentages and absolute numbers. Descriptive statistics were obtained for all subpopulations identified in each of the groups studied, and Student t test was performed to compare results between groups with appropriate adjustment for equal and unequal variance. P values of less than 0.05 were taken as significant. All the results were analyzed by SPSS 11.0 software.
RESULTS
Lymphocyte Subpopulations in Patients Versus Controls
Absolute lymphocyte count and individual lymphocyte subpopulations were significantly decreased in the patient group compared with the healthy controls. Only the population of activated T lymphocytes (CD3+DR+) was more abundant in end-stage liver disease patients than in controls (Fig. 1) . When comparisons were established in subpopulation percentages rather than absolute lymphocyte numbers, some of the significances were lost, whereas others remained. When compared with controls, end-stage liver disease patients showed a low percentage of CD3+ T cells, specifically TCRab+ and a significant decrease of naive CD45RA+CD4+ T cells, together with high percentages of activated T cells, memory CD45RO+CD4+ T lymphocytes, and CD19+ cells (B lymphocytes) ( Table 2) .
Patients were then subclassified into groups according to the underlying disease responsible for causing liver failure. Lymphocyte subpopulations were independently calculated in each group and compared with normal controls (Table 2) .
HCV patients (n = 32) showed low number of CD3+ T cells in comparison to the healthy population, although this did not reach statistical significance. The CD3+ subset was decreased mainly at the expense of TCRab+ and CD45RA+CD4+ (naive) cells. On the contrary, activated T cells subset, memory CD4+ cells, and CD19+ B lymphocytes were found significantly augmented in patients with chronic liver failure due to HCV infection. HBV patients (n = 3) showed low percentages of CD4+, mainly naive lymphocytes, whereas CD8+ and TCRgd+ subsets were increased with respect to controls.
Seventeen patients suffered end-stage liver disease due to alcohol consumption. Global percentages of T and B cells (CD3+ and CD19+, respectively) were conserved with respect to controls. However, CD8+ subset, TCRab+ lymphocytes and naive (CD4+ and CD8+) populations were significantly decreased. Activated CD3+DR+ and memory CD45RO+CD4+ lymphocytes were significantly higher in alcoholic cirrhotic (AC) than in healthy subjects.
Hepatocellular carcinoma patients (n = 9) showed minor disturbances in their lymphophenotypes. They only had a significant increase of activated CD3+DR+ T cells and a slightly significant decrease of memory CD45RO+ CD8+ cells with respect to normal controls.
Patients with autoimmune diseases (n = 3) had the most substantial reduction of CD3+ and TCRab+ subpopulation when compared with the healthy group. The remaining cell subsets were not different in patients and controls.
Finally, CD16+ cells (marker of NK cells) were unaffected in the global group of patients and in every patient category.
Lymphocyte Subpopulations in Specific Diseases
Lymphocyte subpopulations in each group of patients (VHC, VHB, alcoholic cirrhosis, hepatocellular carcinoma, and autoimmune diseases) were compared with data obtained in the remaining patients with chronic liver failure (ie, VHC vs. non-VCH, VHB vs. non-VHB, alcoholic cirrhosis vs. nonalcoholic cirrhosis, hepatocellular carcinoma vs. nonhepatocellular carcinoma and autoimmune diseases vs. nonautoimmune diseases) (Table 3 and Figs. 2, 3).
End-stage liver disease patients due to VHC infection presented with a higher number and percentage of activated T lymphocyte counts, mainly of the CD4+ phenotype, than non-VHC patients. In addition, VHC patients had a significant increase of CD4+ memory cells together with a decrease of CD4+naive cells, in comparison to patients with the remaining pathologies.
HBV patients showed considerably high absolute number of TCRgd+ and virgin CD8+ cells whereas the remaining cellular populations were similar to those in non-HBV patients. When percentages were compared, these significances disappeared and the CD8+ cell subset was the only one that was found augmented in HBV patients.
Absolute number of the total lymphocyte population and of each cellular subset were lower in pretransplant AC subjects in comparison to the remaining patients, although the differences did not reach statistical significance (Fig. 3) . Nonetheless, the representation in percentages of some cellular subsets was altered in the group of AC patients in comparison to non-ACs: the total CD8+ subpopulation, notably the CD8+ subset of naive phenotype was considerably decreased, and the CD4+ cells of memory phenotype were significantly increased (Table 3) . Overall, hepatocellular carcinoma patients had higher lymphocyte counts than patients waiting for liver transplantation by the remaining causes (Fig. 3) , with the exception of activated and memory CD4+ cells, which were diminished in cancer patients. Patients suffering from an autoimmune hepatic disease (AO group) showed the lowest counts of lymphocyte populations in absolute numbers, with statistically significant reductions in CD4+ and CD4+DR+ cellular subsets (Fig. 3) . Interestingly, however, the proportion of lymphocyte subsets was similar in AO and non-AO groups (Table 3) .
Finally, we did not find important modifications of B cells (CD19+) and NK lymphocytes (CD16+) in any of the groups of patients analyzed.
DISCUSSION
In the last years, immunologic mechanisms have been invoked to explain the liver damage in the most common diseases leading to chronic failure of the liver. The study of intrahepatic lymphocytary subpopulations has shed light on the specific mechanisms of injury or disease control into the organ, mainly in viral or alcohol diseases of the liver. However, as these studies are difficult to accomplish in routine clinical practice, it would be of great value to find significant parameters that could be monitored in peripheral blood. Some authors support that a clear correlation exists between intrahepatic and peripheral lymphocyte subsets because there is a cellular exchange between both compartments. [12] [13] [14] Chronic liver disease patients usually show thrombocytopenia and/or leukopenia. In the series studied by us, we have found that patients also show low number of circulating lymphocytes, and this reduction affects every cellular subpopulation analyzed, except the population of activated T lymphocytes, which is higher in patients than in controls (Fig. 1) . Peripheral blood cytopenias have been usually attributed to functional over activity of the spleen (hypersplenism).
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Despite this when the percentual composition of lymphocytes is studied, only some subsets are altered (Tables 2, 3) . With respect to healthy controls, CD3+ cells, representing the total T cells population, are significantly low in the patient group, but when each subgroup of patients is analyzed separately, only the AO patient group shows an important decrease of CD3+ cells. A significant reduction of the CD3+ subset is not a specific characteristic of any of the analyzed diseases in the chronic liver insufficiency phase. Somewhat consistent with the decrease in CD3+ cells, the TCRab+ subset is also lower in every disease compared with controls, particularly in the AO group. CD4+ and CD8+ subsets are mostly conserved, except in the chronic HBV+ group of patients that in agreement with other authors 16 show elevated number of CD8+ cells.
Irrespectively of the disease analyzed, activated T lymphocytes, represented by the CD3+ cells expressing DR antigens on their surface (CD3+DR+ subset), are found significantly increased in comparison to the healthy population; this is probably concordant with a sustained presence of antigen and the chronic inflammatory process of the liver. High number of activated T cells in peripheral blood and in liver biopsies have also been reported by others, mainly in chronic HCV patients or liver disease by chronic alcohol abuse. [17] [18] [19] [20] Probably associated with the maintained hepatic inflammation, is the disturbed balance between naive (CD45RA+) and memory (CD45RO+) cellular populations observed in the patient group, mostly affecting lymphocytes with a helper (CD4+) phenotype. On the contrary to controls, memory cell subsets predominate over virgin cells in patients. This finding is characteristically pronounced in VHC+ and alcoholic cirrhosis patients that exhibit almost twice as many memory rather than naive lymphocytes. Musialik et al 21 postulate that the high memory/low naive cellular pattern could be the result of the activation of CD4+ T cells by exogenous or endogenous antigens and subsequent loss of part of the cell subset by apoptosis, together with the decline of the thymic capacity for the generation of new CD4+ T cells. The permanent activation of the naive T lymphocytes would lead to a progressive loss of the CD45RA isoform and the acquisition of the CD45RO isoform.
Our work demonstrates that patients with long-term HCV infection have high number of circulating CD3+ activated cells together with low virgin CD4+ T cells; these results have also been obtained by other authors. Panasiuk et al 19 found, in addition, a correlation between the peripheral blood value of activated T cells and the degree of histologic hepatitis activity and fibrosis according to Scheuer scale. Pernollet et al 14 described that a strong correlation exists between the proportion of peripheral CD3+CD56 À conventional T lymphocytes, the intrahepatic CD3+CD56 À T lymphocytes and the severity of hepatic lesions, more specifically with periportal necrosis, the characteristic lesion of chronic hepatitis C. In light of these results, the authors postulate that the detection of CD3+CD56 À cells in peripheral blood of patients suffering from chronic hepatitis C could be a simple and useful parameter to predict liver injury and evaluate the progression of the disease. 12 From our data, the increase of TCRgd population is a specific characteristic of patients with end-stage HBV liver disease. High number of circulating TCRgd lymphocytes have also been reported previously by Nikolopoulou et al 22 in chronic active hepatitis B and by Sing et al 16 in healthy carriers who seroconverted with loss of hepatitis B surface antigen. The livers of patients with viral hepatitis have been shown to contain elevated number of T cells expressing the gd receptor. 23 An immunosurveillance role has been suggested for these cells, as they appear during the chronification progress of hepatitis B 16 and late in the course of other viral infections. 24, 25 In our HBV patients, we also observed a reduction in peripheral blood CD4+ numbers, and no changes in T cells bearing activation markers, in agreement with data obtained by others. 16, 26 We found a significant and specific increase of the CD8+ population, notably of naive (CD45RA) phenotype, in end-stage liver disease patients due to HBV infection probably due to the proliferating activity of the B virus despite lamivudine treatment. As far as we know, this observation has not been described before. However, it is necessary to increase the number of HBV patients studied to draw meaningful conclusions.
Alcoholic cirrhosis is, from our data, the cause of hepatic failure that provokes most important changes in the lymphophenotype of T cells. It is well established in both humans and mice that chronic alcohol abuse consistently produces decreased lymphocytic cell numbers in the circulating blood, together with an increase in the number of T lymphocytes with activation and memory phenotypes. Some studies support that the mechanism for ethanol decreasing lymphoid cell number is Fas-mediated apoptosis of previously activated lymphoid cells. 27, 28 It has been demonstrated that the in vitro treatment with alcohol up regulates the CD45RO expression in the CD4+ T cells, 29 and T cells isolated from alcoholics express markers associated with activation. [30] [31] [32] In agreement with these data, in our cohort of alcoholic patients CD4+ T cells overexpress the CD45RO phenotype.
We have also found that the most prominent and specific alteration in the lymphophenotype of ACs is a decrease in the circulating CD8+, virgin cell subset. Some authors have reported expansion of circulating CD8+, cytotoxic lymphocytes in association with maintained alcohol intake, irrespective of the presence or absence of alcoholic hepatic disease, 33 but other studies describe the expansion of CD8+ cells in peripheral blood in heavy alcohol drinkers without liver disease, attributing a protective role for liver damage to that lymphocyte population. 34 Our data could be in some way concordant with this hypothesis, because low number of CD8+ cells in peripheral blood have been recorded in our sample of alcoholic patients with overt, pretransplant stage cirrhosis. Alternatively, the CD8+, virgin cell decrease observed in periphery would be in agreement with a rapid acquisition of the CD45RO phenotype and the infiltration of liver by these cells, probably in response to the neoantigens expressed in the hepatocyte membranes due to the effect of alcohol. 28, 33, 35 Finally, patients affected with hepatocellular carcinoma and patients with autoimmune diseases show minor disturbances in lymphocyte subsets (Tables 2, 3 ). Hepatocellular carcinoma subjects show an increase of T cells with activated phenotype (CD3+DR+), as found elsewhere 36 but this is a nonspecific change as it can also be observed in patients with a similar stage of hepatic disease from other causes (mainly virus C and alcoholic cirrhosis). Although our population with hepatocellular carcinoma (n = 9) is homogeneous in that none of the patients is virus C or B positive, other characteristics, such as age (ranging from 4 to 67, Table 1 ) introduce disparities in the studied group.
Autoimmune hepatic failure patients show the lowest proportion of CD3+ lymphocytes and the highest proportion of CD19+ cells, in comparison to the remaining diseases and the control group. These findings were reported by others in patients affected of primary biliar cirrhosis. 21 More conclusive results could be obtained by studying larger population samples of hepatocellular carcinoma and autoimmune disease patients.
In conclusion, regardless of the base pathology, patients with end-stage liver disease show a low absolute number of lymphocyte populations compared with the healthy population. However, the differences in lymphophenotype do not depend on the degree of hepatic dysfunction because they are observed in a homogeneous patient population (end-stage, pretransplant patients). We have found that the profiles of lymphocyte subsets are different and specific for every disease causing chronic liver failure.
